Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lise Hobolth

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
The Cochrane Database of Systematic Reviews|October 30, 2018
Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varicesAntony P Zacharias, Rebecca Jeyaraj, Lise Hobolth, et al.
Hepatology Communications|April 26, 2024
A randomized controlled trial of a postdischarge nursing intervention for patients with decompensated cirrhosisMalene Barfod O'Connell, Anne Brødsgaard, Maria Matthè, et al.
Clinical Orthopaedics and Related Research|September 10, 2002
Effect of methylprednisolone on reperfusion after femoral head ischemiaWolf Drescher, Thomas Schneider, Cordelia Becker, et al.
European Journal of Gastroenterology & Hepatology|September 18, 2010
Adherence to guidelines in bleeding oesophageal varices and effects on outcome: comparison between a specialized unit and a community hospitalLise Hobolth, Aleksander Krag, Axel Malchow-Møller, et al.
Hepatology (Baltimore, Md.)|October 25, 2016
Rifaximin has no effect on hemodynamics in decompensated cirrhosis: A randomized, double-blind, placebo-controlled trialNina Kimer, Julie Steen Pedersen, Troels Malte Busk, et al.
European Journal of Gastroenterology & Hepatology|October 31, 2014
Association of markers of bacterial translocation with immune activation in decompensated cirrhosisChristian Mortensen, Jørgen Skov Jensen, Lise Hobolth, et al.
Medicina (Kaunas, Lithuania)|October 30, 2020
Tunneled Peritoneal Catheter for Refractory Ascites in Cirrhosis: A Randomized Case-SeriesNina Kimer, Agnete Nordheim Riedel, Lise Hobolth, et al.
Scandinavian Journal of Gastroenterology|June 23, 2020
Implementation of treatment recommendations for chronic hepatitis B in patients attending specialized hospital care in Denmark - a region wide studySigne Bollerup, Sofie Hallager, Ole Baek, et al.
Scientific Reports|November 17, 2023
Markers of inflammation predict survival in newly diagnosed cirrhosis: a prospective registry studyThit Mynster Kronborg, Henry Webel, Malene Barfod O'Connell, et al.
Journal of Gastroenterology and Hepatology|July 4, 2017
Rifaximin has minor effects on bacterial composition, inflammation, and bacterial translocation in cirrhosis: A randomized trialNina Kimer, Julie S Pedersen, Juliette Tavenier, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
The Cochrane Database of Systematic Reviews|October 30, 2018
Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varicesAntony P Zacharias, Rebecca Jeyaraj, Lise Hobolth, et al.
Hepatology Communications|April 26, 2024
A randomized controlled trial of a postdischarge nursing intervention for patients with decompensated cirrhosisMalene Barfod O'Connell, Anne Brødsgaard, Maria Matthè, et al.
Clinical Orthopaedics and Related Research|September 10, 2002
Effect of methylprednisolone on reperfusion after femoral head ischemiaWolf Drescher, Thomas Schneider, Cordelia Becker, et al.
European Journal of Gastroenterology & Hepatology|September 18, 2010
Adherence to guidelines in bleeding oesophageal varices and effects on outcome: comparison between a specialized unit and a community hospitalLise Hobolth, Aleksander Krag, Axel Malchow-Møller, et al.
Hepatology (Baltimore, Md.)|October 25, 2016
Rifaximin has no effect on hemodynamics in decompensated cirrhosis: A randomized, double-blind, placebo-controlled trialNina Kimer, Julie Steen Pedersen, Troels Malte Busk, et al.
European Journal of Gastroenterology & Hepatology|October 31, 2014
Association of markers of bacterial translocation with immune activation in decompensated cirrhosisChristian Mortensen, Jørgen Skov Jensen, Lise Hobolth, et al.
Medicina (Kaunas, Lithuania)|October 30, 2020
Tunneled Peritoneal Catheter for Refractory Ascites in Cirrhosis: A Randomized Case-SeriesNina Kimer, Agnete Nordheim Riedel, Lise Hobolth, et al.
Scandinavian Journal of Gastroenterology|June 23, 2020
Implementation of treatment recommendations for chronic hepatitis B in patients attending specialized hospital care in Denmark - a region wide studySigne Bollerup, Sofie Hallager, Ole Baek, et al.
Scientific Reports|November 17, 2023
Markers of inflammation predict survival in newly diagnosed cirrhosis: a prospective registry studyThit Mynster Kronborg, Henry Webel, Malene Barfod O'Connell, et al.
Journal of Gastroenterology and Hepatology|July 4, 2017
Rifaximin has minor effects on bacterial composition, inflammation, and bacterial translocation in cirrhosis: A randomized trialNina Kimer, Julie S Pedersen, Juliette Tavenier, et al.
Pageof 4